Skip to main content
Resonant Link Medical logo

Resonant Link Medical

Burlington, VermontFounded 2017

  • Series A
Open roles
1
Posted last 30 days
1
Raised
$12.9M
Jan 2025
Series A
Investors
12

reccy insights

Recent highlights

Resonant Link’s January 28, 2025 Series A raised $3.425 million, with Features Capital leading alongside Third Sphere and the Vermont Center for Emerging Technologies. On April 8, 2025, the company announced Omari Bouknight’s appointment as chief executive officer. A November 5, 2025 announcement presented the launch of Resonant Link Medical, focused on implantable devices, and named Bouknight CEO and Raymond Cohen board chair. The company also announced a collaboration with Advanced Charging Technologies on February 10, 2025, expanding ACT’s charging portfolio with Resonant Link wireless power technology. Several patent applications published in 2024 and 2025 cover areas including wireless power transfer for implantable devices, high-efficiency coils, telemetry through wireless power, and synchronous rectifier control. These milestones show activity across financing, medical-device applications, commercial relationships, leadership, and technical development.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Open roles1

What makes Resonant Link Medical distinct

  1. 01The company describes its wireless power technology as delivering five times higher performance for faster charging, easier alignment, and higher efficiency.
  2. 02Its multilayer self-resonant structure (MSRS) is described as achieving up to six times higher Q than conventional wireless charging technologies.
  3. 03It combines wireless charging structures with multi-MHz power electronics.
  4. 04Its products address both implantable medical devices and demanding industrial applications, including lift trucks and automated vehicles.
  5. 05The company says it provides wireless power solutions to Fortune 500 companies and government agencies.

Technology & products6

  • Miniaturized Device Charger

    Wireless power solution providing 15mW continuous power or recharging for millimeter-sized implantable medical devices.

  • 20-Minute IPG Charger

    Wireless charger enabling 20-minute MRI-compatible charging for titanium-encased implantable pulse generators.

  • VAD & TAH Charger

    Wireless charger delivering 10-15 watts of power to ventricular assist devices and total artificial hearts without drivelines.

Recent updates1

  • Apr 8, 2025Team change

    Omari Bouknight was appointed chief executive officer.

    prweb.com

Funding

$12.9M disclosed
  • Series AJan 2025
    $3.4MLed by Features Capital
  • GrantJul 2024
    US Department of Energy
  • Convertible NoteSep 2022
    FreshTracks Capital
12 investors

About Resonant Link Medical

Products
Miniaturized Device Charger, 20-Minute IPG Charger, VAD & TAH Charger, Lift Truck Charger, Automated Vehicle Charger, Drone Charger
Leadership
Omari Bouknight, Chief Executive OfficerAaron Stein, Chief Technology Officer & Co-FounderPhyo Aung Kyaw, Chief Science Officer & Co-FounderRaymond Cohen, Board Chair
Focus areas
Wireless power, wireless charging, power electronics, medical devices, fleet electrification, logistics, transportation, hardware
Headquarters
Burlington, Vermont
Founded
2017
Employees
11–50
Patents granted
1